Google AI
NewsPronto

 

ACN Newswire

Read more press releases from ACN Newswire here

Nanobiotix Announces First Positive Human Data Showing That NBTXR3 Could Become a Backbone in Immuno-Oncology

  • Written by: ACN Newswire

image

- Biomarker two-arm study in 26 Soft Tissue Sarcoma patients- Data shows a specific, adaptive immune pattern triggered by NBTXR3 treatment- Potential synergies with Immuno-oncology drugs including checkpoint inhibitors

Paris, France and Cambridge, Massachusetts, USA, May 18, 2017 - (ACN Newswire) - NANOBIOTIX (Euronext: NANO - ISIN:...

Read more: Nanobiotix Announces First Positive Human Data Showing That NBTXR3 Could Become a Backbone in...